212 related articles for article (PubMed ID: 16127675)
1. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada.
Contoyannis P; Hurley J; Grootendorst P; Jeon SH; Tamblyn R
Health Econ; 2005 Sep; 14(9):909-23. PubMed ID: 16127675
[TBL] [Abstract][Full Text] [Related]
2. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
Li X; Guh D; Lacaille D; Esdaile J; Anis AH
Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
[TBL] [Abstract][Full Text] [Related]
3. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
4. In search of a corrected prescription drug elasticity estimate: a meta-regression approach.
Gemmill MC; Costa-Font J; McGuire A
Health Econ; 2007 Jun; 16(6):627-43. PubMed ID: 17238227
[TBL] [Abstract][Full Text] [Related]
5. Estimating price elasticities when there is smuggling: the sensitivity of smoking to price in Canada.
Gruber J; Sen A; Stabile M
J Health Econ; 2003 Sep; 22(5):821-42. PubMed ID: 12946461
[TBL] [Abstract][Full Text] [Related]
6. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
Liu SZ; Romeis JC
Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
[TBL] [Abstract][Full Text] [Related]
7. New estimates of elasticity of demand for healthcare in rural China.
Zhou Z; Su Y; Gao J; Xu L; Zhang Y
Health Policy; 2011 Dec; 103(2-3):255-65. PubMed ID: 22014842
[TBL] [Abstract][Full Text] [Related]
8. Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demand.
Van de Voorde C; Van Doorslaer E; Schokkaert E
Health Econ; 2001 Jul; 10(5):457-71. PubMed ID: 11466806
[TBL] [Abstract][Full Text] [Related]
9. The impact of introducing patient co-payments in Germany on the use of IVF and ICSI: a price-elasticity of demand assessment.
Connolly MP; Griesinger G; Ledger W; Postma MJ
Hum Reprod; 2009 Nov; 24(11):2796-800. PubMed ID: 19625316
[TBL] [Abstract][Full Text] [Related]
10. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
Landsman PB; Yu W; Liu X; Teutsch SM; Berger ML
Am J Manag Care; 2005 Oct; 11(10):621-8. PubMed ID: 16232003
[TBL] [Abstract][Full Text] [Related]
11. Role of health insurance coverage in women's access to prescription medicines.
Ranji UR; Wyn R; Salganicoff A; Yu H
Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
[TBL] [Abstract][Full Text] [Related]
12. Does cost sharing really reduce inappropriate prescriptions among the elderly?
Costa Font J; Gemmill Toyama M
Health Policy; 2011 Jul; 101(2):195-208. PubMed ID: 20889224
[TBL] [Abstract][Full Text] [Related]
13. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
Sarma S; Basu K; Gupta A
Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
[TBL] [Abstract][Full Text] [Related]
14. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
Augurzky B; Göhlmann S; Gress S; Wasem J
Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
[TBL] [Abstract][Full Text] [Related]
15. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE; Morgan S; Hurley J; van Doorslaer E
Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
[TBL] [Abstract][Full Text] [Related]
16. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
[TBL] [Abstract][Full Text] [Related]
17. Disentangling incentives effects of insurance coverage from adverse selection in the case of drug expenditure: a finite mixture approach.
Munkin MK; Trivedi PK
Health Econ; 2010 Sep; 19(9):1093-108. PubMed ID: 20625979
[TBL] [Abstract][Full Text] [Related]
18. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
19. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
Hanley GE; Morgan S
Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
[TBL] [Abstract][Full Text] [Related]
20. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
